Q4 2014 13F Holders as of 12/31/2014
-
Type / Class
-
Equity / COM
-
Number of holders
-
175
-
Total shares
-
64.2M
-
Shares change
-
+1.82M
-
Total reported value, excl. options
-
$2.03B
-
Value change
-
+$74.5M
-
Put/Call ratio
-
0.73
-
Number of buys
-
87
-
Number of sells
-
-78
-
Price
-
$31.68
Significant Holders of IMPAX LABORATORIES INC - COM (IPXL) as of Q4 2014
181 filings reported holding IPXL - IMPAX LABORATORIES INC - COM as of Q4 2014.
IMPAX LABORATORIES INC - COM (IPXL) has 175 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.2M shares
.
Largest 10 shareholders include ORBIMED ADVISORS LLC (6.68M shares), BlackRock Fund Advisors (5.02M shares), VANGUARD GROUP INC (4.59M shares), Invesco Ltd. (3.31M shares), FMR LLC (3.02M shares), FRANKLIN RESOURCES INC (2.51M shares), State Street Corp (2.45M shares), Slate Path Capital LP (2.33M shares), ARAVT GLOBAL LLC (2.3M shares), and UBS GLOBAL ASSET MANAGEMENT AMERICAS INC (2.1M shares).
This table shows the top 175 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.